According to the "People's Republic of China Environmental Impact Assessment Law", "Environmental Impact Assessment Public Participation Measures" and the relevant provisions of the environmental impact assessment of construction projects, our company publicizes the construction status and environmental impact assessment of the proposed project in order to widely understand the public from all walks of life The attitude towards this project and the opinions and suggestions on environmental protection are accepted by the public.
1. The name and summary of the construction project
Project Name: Shandong Longcom Pharmaceutical Co., Ltd. New Drug R & D Incubation Pilot and Production Project
Project Summary: Shandong Langcom Pharmaceutical Co., Ltd. was established on May 21, 2012, and was established by Shandong Bainuo Pharmaceutical Co., Ltd. It is a modern pharmaceutical technology company that focuses on innovative drug research and development and expands the market with global registration. The company covers an area of 133130.23m2. The factory is located in the Qihe County Pharmaceutical Industrial Park in the north-central part of Shandong Qihe Economic Development Zone, north of Qizhong Avenue, east of Yongya Road, and west of Shandong Delong Baozhen Wine Co., Ltd. The closest sensitive point to the factory boundary of Shandong Langcom Pharmaceutical Co., Ltd. is Dingzhuang Village, 410m away from NNE.
Shandong Longcom Pharmaceutical Co., Ltd.'s new drug research and development incubation pilot and production project covers an area of 15050m2, mainly building 1 R & D office building, 3 warehouses, and 1 incubation laboratory for pilot and production (using existing idle factories) . The project plans to produce a total of 19 innovative drugs including cardio-cerebrovascular, anti-tumor, antimetabolite, anti-allergic and anti-inflammatory analgesics. The total investment of the project is 246 million yuan. Other public auxiliary facilities rely on the company's existing. Heating, power supply and cooling can meet the needs of the proposed project.
The project has been filed with the Development and Reform Commission of Dezhou City, project code: 2017-371425-73-03-069036.
The construction of the proposed project conforms to the national industrial policy, the requirements of local planning and local economic development, the process technology is mature and reliable, the raw material sources are sufficient, and the products have strong market competitiveness. After the project is completed, it can drive related industries and promote local Economic development has better economic and social benefits.
2. Name and contact information of the construction unit
Construction unit: Shandong Langcom Pharmaceutical Co., Ltd.
Address: North of North Road and East of Jingqi Road, Economic Development Zone, Qihe County, Dezhou City, Shandong Province
Contact Person: Yu Changfeng
Phone: 19905347968
E-mail: langnuo5636@163.com
3. Name of the unit that prepared the environmental impact assessment report
EIA unit: Shandong Qingke Environmental Technology Co., Ltd.
4. Web link for public comment form
http://www.mee.gov.cn/xxgk2018/xxgk/xxgk01/201810/t20181024_665329.html
V. Ways and means of submitting public comment forms
The public comment form can be submitted to our unit by mail or email.
It is hereby announced that if any unit or individual has valuable comments or suggestions, they can contact us through the above methods!
Shandong Langnuo Pharmaceutical Co., Ltd.
Phone:086-0531-88114952
Fax:086-0531-88038446
Recruitment:086-0534-5025689
E-mail:info@bestcomm.cn
Address:No.127 Qizhong Avenue, Yanbei Sub-district Office, Qihe County, Dezhou City, Shandong Province
Copyright © 2020 Shandong Loncom Pharmaceutical Co., Ltd. Lu ICP 16013147-1 FDA registration number: (Lu)-non-operating-2016-0017